Literature DB >> 16926297

Does liver biopsy overestimate liver iron concentration?

Roland Fischer, Paul Harmatz, Peter Nielsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16926297     DOI： 10.1182/blood-2006-03-013482

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Italian Society of Hematology guidelines for thalassemia and non-invasive iron measurements.

Authors:  Peter Nielsen; Rainer Engelhardt; Regine Grosse; Gritta Janka; Paul Harmatz; Roland Fischer
Journal:  Haematologica       Date:  2008-12-23       Impact factor: 9.941

Review 2.  Deferasirox for managing iron overload in people with thalassaemia.

Authors:  Claudia Bollig; Lisa K Schell; Gerta Rücker; Roman Allert; Edith Motschall; Charlotte M Niemeyer; Dirk Bassler; Joerg J Meerpohl
Journal:  Cochrane Database Syst Rev       Date:  2017-08-15

3.  Iron overload in transfusion-dependent survivors of hemoglobin Bart's hydrops fetalis.

Authors:  Ali Amid; Shiyi Chen; Uma Athale; Karen Charpentier; Manuela Merelles-Pulcini; Isaac Odame; Melanie Kirby-Allen
Journal:  Haematologica       Date:  2018-01-25       Impact factor: 9.941

4.  Simultaneous field and R2 mapping to quantify liver iron content using autoregressive moving average modeling.

Authors:  Brian A Taylor; Ralf B Loeffler; Ruitian Song; M Beth McCarville; Jane S Hankins; Claudia M Hillenbrand
Journal:  J Magn Reson Imaging       Date:  2011-12-16       Impact factor: 4.813

Review 5.  Optimal management strategies for chronic iron overload.

Authors:  James C Barton
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Deferasirox : a review of its use in the management of transfusional chronic iron overload.

Authors:  Lily P H Yang; Susan J Keam; Gillian M Keating
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.

Authors:  Elliott Vichinsky; Onyinye Onyekwere; John Porter; Paul Swerdlow; James Eckman; Peter Lane; Beatrice Files; Kathryn Hassell; Patrick Kelly; Felicia Wilson; Françoise Bernaudin; Gian Luca Forni; Iheanyi Okpala; Catherine Ressayre-Djaffer; Daniele Alberti; Jaymes Holland; Peter Marks; Ellen Fung; Roland Fischer; Brigitta U Mueller; Thomas Coates
Journal:  Br J Haematol       Date:  2007-02       Impact factor: 6.998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.